Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Jefferson Research
|
$20.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Amgen, Inc. Announces 2012 Third Quarter Dividend
Amgen, Inc. announced that its Board of Directors declared a $0.36 per share dividend for the third quarter of 2012. The dividend will be paid on Sept. 7, 2012, to all stockholders of record as of the close of business on Aug. 16, 2012.
Latest Developments for Amgen Inc
- Amgen Inc Reaffirms FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance
- Amgen Inc Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma
- FDA Halts Trials Of Amgen Inc Drug In Children, Cites Death-Reuters
- Amgen Inc Updates FY 2015 Guidance To A Range In Line With Analysts' Estimates-Conference Call
Latest Key Developments in Biotechnology
- Share this
- Link this
- Digg this


Follow Reuters